During the past decade, Specjalistyczny Szpital Onkologiczny NU-MED conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Specjalistyczny Szpital Onkologiczny NU-MED" #1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Specjalistyczny Szpital Onkologiczny NU-MED" are "Lymphoma, Mantle-Cell" (1 trials), "Melanoma Stage III" (1 trials), "Melanoma Stage IV" (1 trials) and "Unresectable Melanoma" (1 trials). Many other conditions were trialed in "Specjalistyczny Szpital Onkologiczny NU-MED" in a lesser frequency.

Most popular intervention types in "Specjalistyczny Szpital Onkologiczny NU-MED" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BNT111" (1 trials), "Bortezomib" (1 trials), "Cemiplimab" (1 trials), "Ibrutinib" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specjalistyczny Szpital Onkologiczny NU-MED" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Specjalistyczny Szpital Onkologiczny NU-MED". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Specjalistyczny Szpital Onkologiczny NU-MED, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specjalistyczny Szpital Onkologiczny NU-MED, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".